# Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects

> **NCT04422600** · — · COMPLETED · sponsor: **University of Arkansas** · enrollment: 72 (actual)

## Conditions studied

- Fetal Exposure Timing Unspecified

## Interventions

- **OTHER:** There is no other intervention, only clinical treatment.

## Key facts

- **NCT ID:** NCT04422600
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-26
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04422600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04422600, "Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04422600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*